摘要
为观察秘宝康治疗血虚肠燥型便秘的临床疗效,将60例血虚肠燥型便秘患者随机分为观察组和对照组,每组30例。观察组给予秘宝康口服治疗,对照组给予麻仁软胶囊及西沙比利片口服治疗,对比两组患者总体疗效、便秘症状评分及不良反应。结果显示,观察组有效率为93.3%(28/30),对照组有效率为80.0%(24/30),观察组有效率明显高于对照组(P〈0.05)。治疗后观察组排便间隔时间、排便时间、大便性状、排便方式评分明显低于对照组(P〈0.05)。观察组无明显的不良反应,对照组有2例服药后出现轻微的腹痛、腹泻、头晕、乏力,经过对症处理后症状消失。结果表明,秘宝康口服治疗血虚肠燥型便秘疗效肯定,无不良反应。
This study was to observe the clinical efficacy of Mibaokang for constipation due to blood deficiency and intestinal dryness,60 cases were randomly divided into observation group and control group,30 cases for each group.The former was given oral Mibaokang,while the latter was given oral Maren soft capsules and cisapride tablets.Both groups were compared for general clinical efficacy, scores of constipation and adverse reactions.The results showed that the effective rate was 93.3 ~/00 (28/30)in observation group, which was significantly higher than that in the controls [-80.0~ (24/30)1 ( P (0.05).The scores of defeca- tion interval,defecation duration and pattern, consistency of stools, were significantly lower in observation group than in control group( P (0.05).No obvious adverse reactions occurred in observation group,but in control group 2 cases developed mild abdominal pain, diarrhea,dizziness and fatigue,which disappeared af- ter symptomatic treatment.It is concluded that Mibaokang is effective reliable for constipation due to blood deficiency and intestinal dryness and this treatment has no adverse reactions.
出处
《中国肛肠病杂志》
2015年第3期21-22,共2页
Chinese Journal of Coloproctology
关键词
便秘
血虚肠燥型
秘宝康
Constipation
Type of blood deficiency and intestinal dryness
Mibaokang